← USPTO Patent Applications

ORAL MUCOSAL FORMULATIONS OF ASPIRIN

Application US20260090985A1 Kind: A1 Apr 02, 2026

Inventors

James Dzandu

Abstract

Disclosed herein, in part, are pharmaceutical formulations for oral mucosal (e.g., sublingual and/or buccal) administration comprising micronized aspirin, (e.g., 91 mg to 200 mg micronized aspirin), a buffer, a surfactant, and one or more pharmaceutically acceptable excipients, wherein the pH of a solution of the formulation dissolved in 1 mL distilled water is less than or equal to 3. Methods of treating a subject in need thereof comprising administering one or more disclosed pharmaceutical formulations to the subject are also provided herein.

CPC Classifications

A61K 9/006 A61K 9/1611 A61K 9/1617 A61K 9/1629 A61K 31/192 A61P 9/04

Filing Date

2025-10-02

Application No.

19348728